Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Public ClinicalTrials.gov record NCT03021928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Title: Optimal Delay Time to Initiate Anticoagulation after Ischemic Stroke in Atrial Fibrillation (START): a pragmatic, adaptive randomized clinical trial. Primary Objective: • To determine the optimal time to initiate anticoagulation with a Non-Vitamin K Oral Anticoagulant (NOAC) after ischemic stroke in patients with non-valvular atrial fibrillation. Secondary Objectives: * To compare the rates of primary adverse outcomes in a per protocol analysis * To compare 30 day clinical outcomes by the modified Rankin scale among the time-to-treatment groups * To compare 90 day clinical outcomes by the modified Rankin scale among the time-to-treatment groups * To explore the optimal timing in subgroups of age, sex, outcome category, and NOAC choice
Study identification
- NCT ID
- NCT03021928
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 13, 2017
- Primary completion
- Aug 2, 2023
- Completion
- Nov 30, 2023
- Last update posted
- Aug 7, 2023
2017 – 2023
United States locations
- U.S. sites
- 15
- U.S. states
- 1
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dell Seton Medical Center at The University of Texas | Austin | Texas | 78701 | — |
| Seton Medical Center Austin | Austin | Texas | 78705 | — |
| St. David's Medical Center | Austin | Texas | 78705 | — |
| CHI St. Joseph Health Regional Hospital | Bryan | Texas | 77802 | — |
| Texas Health Presbyterian Hospital | Dallas | Texas | 75231 | — |
| Parkland Memorial Hospital | Dallas | Texas | 75235 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| UT Southwestern William P. Clements Hospital | Dallas | Texas | 75390 | — |
| UT Southwestern Zale Lipshy University Hospital | Dallas | Texas | 75390 | — |
| Texas Tech University Health Science Center - El Paso University Medical Center | El Paso | Texas | 79905 | — |
| Texas Health Harris Methodist Hospital | Fort Worth | Texas | 76104 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Seton Medical Center Hays | Kyle | Texas | 78640 | — |
| Seton Medical Center Williamson | Round Rock | Texas | 78665 | — |
| The University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03021928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2023 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03021928 live on ClinicalTrials.gov.